Angiotech Enters Licensing And Distribution Agreement


Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) entered a license, distribution and supply agreement for Haemacure's proprietary fibrin and thrombin technology. The stock price climbed 34 cents to close at $1.89.

About this Entry

This page contains a single entry by published on June 3, 2009 2:43 PM.

JetBlue To Sell 20 Million Common Shares was the previous entry in this blog.

Intel Offers $884 Million For Wind River is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12